Document is current
Any future updates will be listed below
-
Authors
Weiler, Michael J.
Cribb, Matthew T. https://orcid.org/0000-0001-7691-3998
Nepiyushchikh, Zhanna
Nelson, Tyler S.
Dixon, J. Brandon https://orcid.org/0000-0003-0351-4587
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL113061, R01 HL113061, R01 HL113061, R01 HL113061)
American Heart Association (16PRE27390011)
- License Information
-
More Information
Article History
Received: 17 October 2016
Accepted: 5 July 2019
First Online: 18 July 2019
Competing Interests
: Georgia Tech has licensed technology to LymphaTech that is related to this study and that is covered by patent applications for which M.W., T.N. and B.D are inventors. M.W. and B.D. own equity in LymphaTech and B.D. serves as a scientific advisor. In addition, M.W., T.N. and B.D are eligible to receive royalties under the license agreement with LymphaTech.
